Tarsons Products
NSE: TARSONS · Medical Equipment & Supplies
Snapshot
Unlock Tarsons Products's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Tarsons Products Limited is an Indian manufacturer and trader specialising in high-quality plastic laboratory products and scientific instruments. The company serves diverse research sectors including molecular biology, genomics, proteomics, and immunology.
Business Model
The company generates revenue through the manufacturing and distribution of a wide range of laboratory consumables and equipment, including liquid handling systems and cryo labware. It operates as a key supplier to research institutions and laboratories both domestically and internationally.
- Incorporation Year:1983
Growth Outlook
Growth is driven by the increasing demand for high-precision laboratory consumables in the expanding life sciences and healthcare research sectors. The company continues to leverage its established manufacturing capabilities to cater to both domestic and global scientific markets.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of plastic resins and other raw materials can significantly impact manufacturing margins.
- Regulatory Compliance. The company must adhere to stringent international quality standards for laboratory equipment to maintain its market access.
- Competitive Pressure. Intense competition from both domestic and international manufacturers of laboratory plasticware may exert pressure on pricing and market share.
- Geopolitical and Export Risks. As an exporter, the company is susceptible to changes in international trade policies, currency fluctuations, and global supply chain disruptions.
Start your research today
Unlock AI insights, financials, peers and live data on Tarsons Products and 5,000+ companies — free.
Key Metrics
REVENUE
₹441 Cr
TTM · consolidated
NET PROFIT
₹11 Cr
TTM · consolidated
EPS
₹2.09
TTM · consolidated
RETURN ON EQUITY
1.8%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
4.5%
TTM · consolidated
P/E
157.6×
Q1 FY27 · consolidated
EV/EBITDA
14.7x
Q1 FY27 · consolidated
EBITDA MARGIN
33.1%
TTM · consolidated
NET PROFIT MARGIN
-1.3%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.6x
Q1 FY27 · consolidated
Peers · Medical Equipment & Supplies
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Tarsons ProductsTARSONS | ₹1,785 Cr | 157.6× | 14.68 | 10.6% | 33.1% | 1.8% | 4.5% | +6.6% |
Fischer Medical Ventures LimitedFISCHER | ₹2,272 Cr | 13.9× | 41.34 | 196.0% | 15.4% | 7.7% | 12.8% | -68.9% |
Laxmi DentalLAXMIDENTL | ₹1,072 Cr | 34.3× | 19.35 | — | 19.2% | 13.7% | 13.3% | -40.8% |
Hemant Surgical Industries LimitedHSIL | ₹894 Cr | — | — | — | 10.0% | — | — | +91.5% |
Vasa Denticity LimitedDENTALKART | ₹718 Cr | — | — | — | 4.2% | — | — | -24.1% |
Prevest DenproPREVEST | ₹461 Cr | — | — | — | 36.0% | — | — | -31.1% |
As of Q1 FY27
Financials
Tarsons Products
NSE: TARSONS · Medical Equipment & Supplies
Snapshot
Unlock Tarsons Products's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Tarsons Products Limited is an Indian manufacturer and trader specialising in high-quality plastic laboratory products and scientific instruments. The company serves diverse research sectors including molecular biology, genomics, proteomics, and immunology.
Business Model
The company generates revenue through the manufacturing and distribution of a wide range of laboratory consumables and equipment, including liquid handling systems and cryo labware. It operates as a key supplier to research institutions and laboratories both domestically and internationally.
- Incorporation Year:1983
Growth Outlook
Growth is driven by the increasing demand for high-precision laboratory consumables in the expanding life sciences and healthcare research sectors. The company continues to leverage its established manufacturing capabilities to cater to both domestic and global scientific markets.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of plastic resins and other raw materials can significantly impact manufacturing margins.
- Regulatory Compliance. The company must adhere to stringent international quality standards for laboratory equipment to maintain its market access.
- Competitive Pressure. Intense competition from both domestic and international manufacturers of laboratory plasticware may exert pressure on pricing and market share.
- Geopolitical and Export Risks. As an exporter, the company is susceptible to changes in international trade policies, currency fluctuations, and global supply chain disruptions.
Start your research today
Unlock AI insights, financials, peers and live data on Tarsons Products and 5,000+ companies — free.
Key Metrics
REVENUE
₹441 Cr
TTM · consolidated
NET PROFIT
₹11 Cr
TTM · consolidated
EPS
₹2.09
TTM · consolidated
RETURN ON EQUITY
1.8%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
4.5%
TTM · consolidated
P/E
157.6x
Q1 FY27 · consolidated
EV/EBITDA
14.7x
Q1 FY27 · consolidated
EBITDA MARGIN
33.1%
TTM · consolidated
NET PROFIT MARGIN
-1.3%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.6x
Q1 FY27 · consolidated
Peers · Medical Equipment & Supplies
As of Q1 FY27